Virus replication and disease progression inversely correlate with SIV tat evolution in morphine-dependent and SIV/SHIV-infected Indian rhesus macaques

Virology

Volumn 346, Issue 1, 2006, Pages 127-138

  Noel Jr , Richard J ^a   Kumar, Anil ^a  

^a PONCE SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

AIDS; Macaques; Morphine dependence; SHIV; SIV

Indexed keywords

MORPHINE; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MICROBIAL DIVERSITY; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EVOLUTION, MOLECULAR; EXONS; GENE PRODUCTS, TAT; GENES, TAT; HIV INFECTIONS; HIV-1; HUMANS; MACACA MULATTA; MALE; MOLECULAR SEQUENCE DATA; MORPHINE DEPENDENCE; SEQUENCE ANALYSIS, DNA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MACACA; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 32844461707     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2005.10.026     Document Type: Article

References (79)

1. M.M. Addo, M. Altfeld, E.S. Rosenberg, R.L. Eldridge, M.N. Philips, K. Habeeb, A. Khatri, C. Brander, G.K. Robbins, G.P. Mazzara, P.J. Goulder, and B.D. Walker The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals Proc. Natl. Acad. Sci. U.S.A. 98 2001 1781 1786
2. M.M. Addo, X.G. Yu, E.S. Rosenberg, B.D. Walker, and M. Altfeld Cytotoxic T-lymphocyte (CTL) responses directed against regulatory and accessory proteins in HIV-1 infection DNA Cell Biol. 21 2002 671 678
3. P. Alcabes, and G. Friedland Injection drug use and human immunodeficiency virus infection Clin. Infect. Dis. 20 1995 1467 1479
4. T.M. Allen, D.H. O'Connor, P. Jing, J.L. Dzuris, B.R. Mothe, T.U. Vogel, E. Dunphy, M.E. Liebl, C. Emerson, N. Wilson, K.J. Kunstman, X. Wang, D.B. Allison, A.L. Hughes, R.C. Desrosiers, J.D. Altman, S.M. Wolinsky, A. Sette, and D.I. Watkins Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia Nature 407 2000 386 390
5. R.R. Amara, F. Villinger, J.D. Altman, S.L. Lydy, S.P. O'Neil, S.I. Staprans, D.C. Montefiori, Y. Xu, J.G. Herndon, L.S. Wyatt, M.A. Candido, N.L. Kozyr, P.L. Earl, J.M. Smith, H.L. Ma, B.D. Grimm, M.L. Hulsey, J. Miller, H.M. McClure, J.M. McNicholl, B. Moss, and H.L. Robinson Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine Science 292 2001 69 74
6. E. Anderson, W. Zink, H. Xiong, and H.E. Gendelman HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes J. Acquired Immune Defic. Syndr. 31 Suppl 2 2002 S43 S54
7. I.E. Andras, H. Pu, J. Tian, M.A. Deli, A. Nath, B. Hennig, and M. Toborek Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells J. Cereb. Blood Flow Metab. 25 2005 1325 1335
8. W.A. Banks, S.M. Robinson, and A. Nath Permeability of the blood-brain barrier to HIV-1 Tat Exp. Neurol. 193 2005 218 227
9. G. Barillari, R. Gendelman, R.C. Gallo, and B. Ensoli The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence Proc. Natl. Acad. Sci. U.S.A. 90 1993 7941 7945
10. L. Buonaguro, G. Barillari, H.K. Chang, C.A. Bohan, V. Kao, R. Morgan, R.C. Gallo, and B. Ensoli Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines J. Virol. 66 1992 7159 7167
11. A. Caputo, R. Gavioli, G. Altavilla, E. Brocca-Cofano, C. Boarini, M. Betti, A. Castaldello, F. Lorenzini, F. Micheletti, A. Cafaro, K. Sparnacci, M. Laus, L. Tondelli, and B. Ensoli Immunization with low doses of HIV-1 tat DNA delivered by novel cationic block copolymers induces CTL responses against Tat Vaccine 21 2003 1103 1111
12. H.C. Chang, F. Samaniego, B.C. Nair, L. Buonaguro, and B. Ensoli HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region AIDS 11 1997 1421 1431
13. K. Conant, A. Garzino-Demo, A. Nath, J.C. McArthur, W. Halliday, C. Power, R.C. Gallo, and E.O. Major Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia Proc. Natl. Acad. Sci. U.S.A. 95 1998 3117 3121
14. I. Demirhan, A. Chandra, O. Hasselmayer, P. Biberfeld, and P. Chandra Detection of distinct patterns of anti-tat antibodies in HIV-infected individuals with or without Kaposi's sarcoma J. Acquired Immune Defic. Syndr. 22 1999 364 368
15. S. Dominici, M.E. Laguardia, G. Serafini, L. Chiarantini, C. Fortini, A. Tripiciano, E. Brocca-Cofano, A. Scoglio, A. Caputo, V. Fiorelli, R. Gavioli, A. Cafaro, B. Ensoli, and M. Magnani Red blood cell-mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat neutralizing antibodies and CTL Vaccine 21 2003 2073 2081
16. B. Ensoli, G. Barillari, S.Z. Salahuddin, R.C. Gallo, and F. Wong-Staal Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients Nature 345 1990 84 86
17. E.A. Eugenin, G. Dyer, T.M. Calderon, and J.W. Berman HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS Glia 49 2005 501 510
18. M.T. Flaherty, D.A. Hauer, J.L. Mankowski, M.C. Zink, and J.E. Clements Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus J. Virol. 71 1997 5790 5798
19. S.C. Flores, J.C. Marecki, K.P. Harper, S.K. Bose, S.K. Nelson, and J.M. McCord Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells Proc. Natl. Acad. Sci. U.S.A. 90 1993 7632 7636
20. H.G. Guo, S. Pati, M. Sadowska, M. Charurat, and M. Reitz Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat J. Virol. 78 2004 9336 9342
21. J.A. Gurwell, A. Nath, Q. Sun, J. Zhang, K.M. Martin, Y. Chen, and K.F. Hauser Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro Neuroscience 102 2001 555 563
22. T.A. Hall BioEdit: a user friendly biological sequence alignment editor and analysis program for windows95/98/NT Nucleic Acids Symp. Ser. 41 1999 95 98
23. M.E. Hilburger, M.W. Adler, A.L. Truant, J.J. Meissler Jr., V. Satishchandran, T.J. Rogers, and T.K. Eisenstein Morphine induces sepsis in mice J. Infect. Dis. 176 1997 183 188
24. L. Hudson, J. Liu, A. Nath, M. Jones, R. Raghavan, O. Narayan, D. Male, and I. Everall Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues J. Neurovirol. 6 2000 145 155
25. K.T. Jeang, and B. Berkhout Kinetics of HIV-1 long terminal repeat trans-activation. Use of intragenic ribozyme to assess rate-limiting steps J. Biol. Chem. 267 1992 17891 17899
26. M. Jones, K. Olafson, M.R. Del Bigio, J. Peeling, and A. Nath Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement J. Neuropathol. Exp. Neurol. 57 1998 563 570
27. J. Karn Control of human immunodeficiency virus replication by the tat, rev, nef and protease genes Curr. Opin. Immunol. 3 1991 526 536
28. V.K. Khurdayan, S. Buch, N. El Hage, S.E. Lutz, S.M. Goebel, I.N. Singh, P.E. Knapp, J. Turchan-Cholewo, A. Nath, and K.F. Hauser Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro Eur. J. Neurosci. 19 2004 3171 3182
29. R.E. Kiernan, C. Vanhulle, L. Schiltz, E. Adam, H. Xiao, F. Maudoux, C. Calomme, A. Burny, Y. Nakatani, K.T. Jeang, M. Benkirane, and C. Van Lint HIV-1 tat transcriptional activity is regulated by acetylation EMBO J. 18 1999 6106 6118
30. M.E. Klotman, S. Kim, A. Buchbinder, A. DeRossi, D. Baltimore, and F. Wong-Staal Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes Proc. Natl. Acad. Sci. U.S.A. 88 1991 5011 5015
31. A. Kumar, J.D. Lifson, Z. Li, F. Jia, S. Mukherjee, I. Adany, Z. Liu, M. Piatak, D. Sheffer, H.M. McClure, and O. Narayan Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P) Virology 279 2001 241 256
32. A. Kumar, S. Mukherjee, J. Shen, S. Buch, Z. Li, I. Adany, Z. Liu, W. Zhuge, M. Piatak Jr., J. Lifson, H. McClure, and O. Narayan Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus Virology 301 2002 189 205
33. R. Kumar, C. Torres, Y. Yamamura, I. Rodriguez, M. Martinez, S. Staprans, R.M. Donahoe, E. Kraiselburd, E.B. Stephens, and A. Kumar Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus J. Virol. 78 2004 11425 11428
34. R.K. Kundu, F. Sangiorgi, L.Y. Wu, P.K. Pattengale, D.R. Hinton, P.S. Gill, and R. Maxson Expression of the human immunodeficiency virus-Tat gene in lymphoid tissues of transgenic mice is associated with B-cell lymphoma Blood 94 1999 275 282
35. X. Liu, M. Jana, S. Dasgupta, S. Koka, J. He, C. Wood, and K. Pahan Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia J. Biol. Chem. 277 2002 39312 39319
36. + T cell counts on viral evolution in HIV-infected individuals undergoing suppressive HAART Virology 330 2004 116 126
37. Y. Luo, S.J. Madore, T.G. Parslow, B.R. Cullen, and B.M. Peterlin Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells J. Virol. 67 1993 5617 5622
38. A.S. MacFarlane, X. Peng, J.J. Meissler Jr., T.J. Rogers, E.B. Geller, M.W. Adler, and T.K. Eisenstein Morphine increases susceptibility to oral Salmonella typhimurium infection J. Infect. Dis. 181 2000 1350 1358
39. D.S. Magnuson, B.E. Knudsen, J.D. Geiger, R.M. Brownstone, and A. Nath Human immunodeficiency virus type 1 tat activates non-N-methyl-d-aspartate excitatory amino acid receptors and causes neurotoxicity Ann. Neurol. 37 1995 373 380
40. M. Mayne, A.C. Bratanich, P. Chen, F. Rana, A. Nath, and C. Power HIV-1 tat molecular diversity and induction of TNF-alpha: implications for HIV-induced neurological disease Neuroimmunomodulation 5 1998 184 192
41. C.B. Morris, A. Thanawastien, D.E. Sullivan, and J.D. Clements Identification of a peptide capable of inducing an HIV-1 Tat-specific CTL response Vaccine 20 2001 12 15
42. J.R. Munis, R.S. Kornbluth, J.C. Guatelli, and D.D. Richman Ordered appearance of human immunodeficiency virus type 1 nucleic acids following high multiplicity infection of macrophages J. Gen. Virol. 73 Pt 8 1992 1899 1906
43. A. Nath, K. Conant, P. Chen, C. Scott, and E.O. Major Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes, a hit and run phenomenon J. Biol. Chem. 274 1999 17098 17102
44. A. Nath, N.J. Haughey, M. Jones, C. Anderson, J.E. Bell, and J.D. Geiger Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine Ann. Neurol. 47 2000 186 194
45. A. Nath, K.F. Hauser, V. Wojna, R.M. Booze, W. Maragos, M. Prendergast, W. Cass, and J.T. Turchan Molecular basis for interactions of HIV and drugs of abuse J. Acquired Immune Defic. Syndr. 31 Suppl 2 2002 S62 S69
46. A. Nicolini, M.A. Ajmone-Cat, A. Bernardo, G. Levi, and L. Minghetti Human immunodeficiency virus type-1 Tat protein induces nuclear factor (NF)-kappaB activation and oxidative stress in microglial cultures by independent mechanisms J. Neurochem. 79 2001 713 716
47. P.K. Peterson, B.M. Sharp, G. Gekker, P.S. Portoghese, K. Sannerud, and H.H. Balfour Jr. Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures AIDS 4 1990 869 873
48. P.K. Peterson, G. Gekker, C.C. Chao, R. Schut, T.W. Molitor, and H.H. Balfour Jr. Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor-beta J. Immunol. 146 1991 81 84
49. P.K. Peterson, G. Gekker, C.C. Chao, R. Schut, J. Verhoef, C.K. Edelman, A. Erice, and H.H. Balfour Jr. Cocaine amplifies HIV-1 replication in cytomegalovirus-stimulated peripheral blood mononuclear cell cocultures J. Immunol. 149 1992 676 680
50. P.K. Peterson, G. Gekker, R. Schut, S. Hu, H.H. Balfour Jr., and C.C. Chao Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection Adv. Exp. Med. Biol. 335 1993 181 188
51. P.K. Peterson, G. Gekker, S. Hu, W.R. Anderson, F. Kravitz, P.S. Portoghese, H.H. Balfour Jr., and C.C. Chao Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells J. Neuroimmunol. 50 1994 167 175
52. E. Polazzi, G. Levi, and L. Minghetti Human immunodeficiency virus type 1 Tat protein stimulates inducible nitric oxide synthase expression and nitric oxide production in microglial cultures J. Neuropathol. Exp. Neurol. 58 1999 825 831
53. S.M. Raidel, C. Haase, N.R. Jansen, R.B. Russ, R.L. Sutliff, L.W. Velsor, B.J. Day, B.D. Hoit, A.M. Samarel, and W. Lewis Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage Am. J. Physiol.: Heart Circ. Physiol. 282 2002 H1672 H1678
54. J. Rappaport, J. Joseph, S. Croul, G. Alexander, L. Del Valle, S. Amini, and K. Khalili Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat J. Leukocyte Biol. 65 1999 458 465
55. N. Rautonen, J. Rautonen, N.L. Martin, and D.W. Wara HIV-1 Tat induces cytokine synthesis by uninfected mononuclear cells AIDS 8 1994 1504 1506
56. M.C. Re, G. Furlini, M. Vignoli, E. Ramazzotti, G. Roderigo, R. De, V. Zauli, G. Lolli, S. Capitani, and S. La Placa Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivo J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 10 1995 408 416
57. M.C. Re, G. Furlini, M. Vignoli, E. Ramazzotti, G. Zauli, and M. La Placa Antibody against human immunodeficiency virus type 1 (HIV-1) Tat protein may have influenced the progression of AIDS in HIV-1-infected hemophiliac patients Clin. Diagn. Lab. Immunol. 3 1996 230 232
58. M.C. Re, D. Gibellini, F. Vitone, and M. La Placa Antibody to HIV-1 Tat protein, a key molecule in HIV-1 pathogenesis, a brief review New Microbiol. 24 2001 197 205
59. M.C. Re, M. Vignoli, G. Furlini, D. Gibellini, V. Colangeli, F. Vitone, and M. La Placa Antibodies against full-length Tat protein and some low-molecular-weight Tat-peptides correlate with low or undetectable viral load in HIV-1 seropositive patients J. Clin. Virol. 21 2001 81 89
60. K.A. Reimann, J.T. Li, R. Veazey, M. Halloran, I.W. Park, G.B. Karlsson, J. Sodroski, and N.L. Letvin A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys J. Virol. 70 1996 6922 6928
61. K.A. Reimann, J.T. Li, G. Voss, C. Lekutis, K. Tenner-Racz, P. Racz, W. Lin, D.C. Montefiori, D.E. Lee-Parritz, Y. Lu, R.G. Collman, J. Sodroski, and N.L. Letvin An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys J. Virol. 70 1996 3198 3206
62. A.P. Rice, and F. Carlotti Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins J. Virol. 64 1990 6018 6026
63. A.P. Rice, E. Wilson, and F. Chan Limited proteolytic digestions identify common structural features of HIV-1 Tat proteins expressed during infection from alternatively spliced mRNAs J. Acquired Immune Defic. Syndr. 6 1993 344 352
64. P.J. Ronald, J.R. Robertson, and R.A. Elton Continued drug use and other cofactors for progression to AIDS among injecting drug users AIDS 8 1994 339 343
65. S. Ruben, A. Perkins, R. Purcell, K. Joung, R. Sia, R. Burghoff, W.A. Haseltine, and C.A. Rosen Structural and functional characterization of human immunodeficiency virus tat protein J. Virol. 63 1989 1 8
66. M. Rusnati, D. Coltrini, D. Campioni, E. Tanghetti, A. Corallini, G. Barbanti-Brodano, R. Giuliani, D. Gibellini, and M. Presta Upregulation of urokinase-type plasminogen activator by endogenous and exogenous HIV-1 Tat protein in tumour cell lines derived from BK virus/tat-transgenic mice AIDS 11 1997 727 736
67. N. Saitou, and M. Nei The neighbor-joining method: a new method for reconstructing phylogenetic trees Mol. Biol. Evol. 4 1987 406 425
68. P.A. Selwyn, P. Alcabes, D. Hartel, D. Buono, E.E. Schoenbaum, R.S. Klein, K. Davenny, and G.H. Friedland Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection N. Engl. J. Med. 327 1992 1697 1703
69. P.S. Silverstein, G.A. Mackay, S. Mukherjee, Z. Li, M. Piatak Jr., J.D. Lifson, O. Narayan, and A. Kumar Pathogenic simian/human immunodeficiency virus SHIV(KU) inoculated into immunized macaques caused infection, but virus burdens progressively declined with time J. Virol. 74 2000 10489 10497
70. D.K. Singh, C. McCormick, E. Pacyniak, D. Griffin, D.M. Pinson, F. Sun, N.E. Berman, and E.B. Stephens Pathogenic and nef-interrupted simian-human immunodeficiency viruses traffic to the macaque CNS and cause astrocytosis early after inoculation Virology 296 2002 39 51
71. J.D. Thompson, T.J. Gibson, F. Plewniak, F. Jeanmougin, and D.G. Higgins The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools Nucleic Acids Res. 25 1997 4876 4882
72. D. Torre, A. Pugliese, and F. Speranza Role of nitric oxide in HIV-1 infection: friend or foe? Lancet Infect. Dis. 2 2002 273 280
73. K. Verhoef, A. Klein, and B. Berkhout Paracrine activation of the HIV-1 LTR promoter by the viral Tat protein is mechanistically similar to trans-activation within a cell Virology 225 1996 316 327
74. M.O. Westendorp, V.A. Shatrov, K. Schulze-Osthoff, R. Frank, M. Kraft, M. Los, P.H. Krammer, W. Droge, and V. Lehmann HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state EMBO J. 14 1995 546 554
75. J.F. Zagury, A. Sill, W. Blattner, A. Lachgar, H. Le Buanec, M. Richardson, J. Rappaport, H. Hendel, B. Bizzini, A. Gringeri, M. Carcagno, M. Criscuolo, A. Burny, R.C. Gallo, and D. Zagury Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine J. Hum. Virol. 1 1998 282 292
76. G. Zauli, P. Secchiero, L. Rodella, D. Gibellini, P. Mirandola, M. Mazzoni, D. Milani, D.R. Dowd, S. Capitani, and M. Vitale HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells J. Biol. Chem. 275 2000 4159 4165
77. M.C. Zink, and J.E. Clements A novel simian immunodeficiency virus model that provides insight into mechanisms of human immunodeficiency virus central nervous system disease J. Neurovirol. 8 Suppl 2 2002 42 48
78. M.C. Zink, J.P. Spelman, R.B. Robinson, and J.E. Clements SIV infection of macaques-modeling the progression to AIDS dementia J. Neurovirol. 4 1998 249 259
79. M.C. Zink, G.D. Coleman, J.L. Mankowski, R.J. Adams, P.M. Tarwater, K. Fox, and J.E. Clements Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis J. Infect. Dis. 184 2001 1015 1021